Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 3,133

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

for

Advanced Cancer, Clear Cell Renal Cell Carcinoma

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05663710

Phase 1, Phase 2, Recruiting

A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus

for

Cutaneous Lichen Planus

Location: Bellaire TX, Pflugerville TX, San Antonio TX,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07775924

Phase 2, Recruiting

Mechanical Ventilation in Obese Surgical Patients

for

Obese

Location: Galveston TX

Sponsor: The University of Texas Medical Branch, Galveston

Sex: All

Age: 18+

Code: NCT07774065

Recruiting

Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

for

Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT00412594

Phase 2, Recruiting

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

for

Gastrointestinal Stromal Neoplasms

Location: Houston TX, Kansas City MO, Knoxville TN, Omaha NE,

Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07585266

Phase 3, Recruiting

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

for

Narcolepsy, Idiopathic Hypersomnia

Location: Sugar Land TX, Austin TX, Dallas TX, Birmingham AL,

Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07625280

Phase 3, Recruiting

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

for

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms,

Location: Houston TX, Baytown TX, The Woodlands TX, Austin TX,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07218380

Phase 3, Recruiting

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

for

Plaque Psoriasis

Location: Bellaire TX, San Antonio TX, Charleston SC,

Sponsor: Takeda

Sex: All

Age: 4 - 17

Code: NCT07250802

Phase 3, Recruiting

Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

for

Peritoneal Malignant Mesothelioma

Location: Houston TX, Sugar Land TX, League City TX, Conroe TX,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05001880

Phase 2, Recruiting

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

for

Acute Myeloid Leukemia,

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 1+

Code: NCT03630991

Phase 1, Recruiting

Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry

for

Thoracic Tumors

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06840288

Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for

Prostatic Neoplasms, Castration-Resistant

Location: Houston TX, The Woodlands TX, Sugar Land TX, Austin TX,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase 3, Recruiting

Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce

for

COVID-19 Infection

Location: Houston TX

Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04491292

Recruiting

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

for

Advanced or Metastatic Solid Tumors

Location: Houston TX, San Antonio TX, Irving TX, Nashville TN,

Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07205718

Phase 1, Phase 2, Recruiting

A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

for

Advanced/Metastatic Solid Tumors

Location: Houston TX, San Antonio TX, Ann Arbor MI, Pittsburgh PA,

Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT07141706

Phase 1, Recruiting

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

for

Atopic Dermatitis

Location: Sugar Land TX, Pflugerville TX, Dallas TX, Bolivar MO,

Sponsor: Sanofi

Sex: All

Age: 12+

Code: NCT07290803

Recruiting

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

for

Symptomatic Venous Thromboembolism (VTE)

Location: Houston TX, San Antonio TX, McAllen TX, Wichita KS,

Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07213778

Phase 3, Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

for

Melanoma (Skin Cancer),

Location: Houston TX, Austin TX, Dallas TX, Laredo TX, Fairway KS,

Sponsor: Aminex Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07287917

Phase 1, Phase 2, Recruiting

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

for

Nausea, Vomiting,

Location: Houston TX, Baytown TX, Fort Worth TX, Tupelo MS,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07169851

Phase 2, Recruiting

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for

Breast Cancer

Location: Houston TX, Sugar Land TX, League City TX, Conroe TX,

Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07062965

Phase 3, Recruiting

Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country

Houston Has More Recruiting Clinical Trials Than Any US City

Paid Clinical Trials Houston

Filter results

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus

Mechanical Ventilation in Obese Surgical Patients

Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

Interested in new trials?

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.